BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3282476)

  • 1. Immunobiology of a spontaneously regressive tumor, the canine transmissible venereal sarcoma (review).
    Yang TJ
    Anticancer Res; 1988; 8(1):93-5. PubMed ID: 3282476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoelectron microscopic localization of a tumor-associated antigen (TAA) in the canine transmissible venereal sarcoma by anti-TAA-antiferritin hybrid antibodies.
    Hill DL; Yang TJ
    J Natl Cancer Inst; 1985 Oct; 75(4):725-32. PubMed ID: 3900513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth stage dependent expression of MHC antigens on the canine transmissible venereal sarcoma.
    Yang TJ; Chandler JP; Dunne-Anway S
    Br J Cancer; 1987 Feb; 55(2):131-4. PubMed ID: 2949770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine transmissible venereal sarcoma: quantitation of T-lymphocyte subpopulations during progressive growth and spontaneous tumor regression.
    Trail PA; Yang TJ
    J Natl Cancer Inst; 1985 Feb; 74(2):461-7. PubMed ID: 3871871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor infiltrating lymphocytes: CD8+ lymphocytes in canine transmissible venereal sarcomas at different stages of tumor growth.
    Barber MR; Yang TJ
    Anticancer Res; 1999; 19(2A):1137-42. PubMed ID: 10368665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
    Harding MW; Yang TJ
    Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine transmissible venereal sarcoma: tumor cell and infiltrating leukocyte ultrastructure at different growth stages.
    Hill DL; Yang TJ; Wachtel A
    Vet Pathol; 1984 Jan; 21(1):39-45. PubMed ID: 6710811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of humoral immunity in progressive and regressive and metastatic growth of the canine transmissible venereal sarcoma.
    Fenton MA; Yang TJ
    Oncology; 1988; 45(3):210-3. PubMed ID: 3368197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus-induced regression of canine transmissible venereal sarcoma.
    Yang TJ
    Am J Vet Res; 1987 May; 48(5):799-800. PubMed ID: 3035973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by canine interferon-gamma of major histocompatibility complex and tumor-associated antigen expression in canine mammary tumor and melanoma cell lines.
    Whitley EM; Bird AC; Zucker KE; Wolfe LG
    Anticancer Res; 1995; 15(3):923-9. PubMed ID: 7645983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
    Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lymphocytes in spontaneous regression of experimentally transplanted canine transmissible venereal sarcoma.
    Mizuno S; Fujinaga T; Hagio M
    J Vet Med Sci; 1994 Feb; 56(1):15-20. PubMed ID: 8204742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
    Mukaratirwa S; Gruys E
    Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of beta 2-microglobulin on the surface of canine transmissible venereal tumor cells.
    Cohen D; Shalev A; Krup M
    J Natl Cancer Inst; 1984 Feb; 72(2):395-401. PubMed ID: 6363791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and physicochemical characterization of a tumor-associated antigen from canine transmissible venereal sarcoma.
    Palker TJ; Yang TJ
    J Natl Cancer Inst; 1981 Apr; 66(4):779-87. PubMed ID: 6939924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of in vitro immune response with clinical course of malignant neoplasia in dogs.
    Brodey RS; Fidler IJ; Bech-Nielsen S
    Am J Vet Res; 1975 Jan; 36(1):75-80. PubMed ID: 1054221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
    Hsiao YW; Liao KW; Hung SW; Chu RM
    Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation characteristics of canine transmissible venereal tumor.
    Chu RM; Lin CY; Liu CC; Yang SY; Hsiao YW; Hung SW; Pao HN; Liao KW
    Anticancer Res; 2001; 21(6A):4017-24. PubMed ID: 11911286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine transmissible venereal sarcoma: distribution of T and B lymphocytes in blood, draining lymph nodes and tumours at different stages of growth.
    Chandler JP; Yang TJ
    Br J Cancer; 1981 Oct; 44(4):514-21. PubMed ID: 6975111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.